18 and older, any sex, with Caregiver Burden. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Pearlin Mastery, Loss, and Competence: Caregiver Competence SubscalePrimary· at baseline, upon training completion (Week 4), and three months post baseline.
4-item Likert-type scale; scores range from 4 to 16 with higher scores indicating greater feelings of competence.
Baseline
Group
Value
95% CI
Caregivers
11.10
± 2.31
Month 1
Group
Value
95% CI
Caregivers
11.63
± 2.07
Month 3
Group
Value
95% CI
Caregivers
11.93
± 2.06
Perceived Stress ScaleSecondary· at baseline, upon training completion (Week 4), and three months post baseline.
14-item Likert-type scale. Scores range from 0 to 56 with higher scores indicating greater stress.
Baseline
Group
Value
95% CI
Caregivers
26.25
± 8.43
Month 1
Group
Value
95% CI
Caregivers
26.65
± 9.45
Month 3
Group
Value
95% CI
Caregivers
23.10
± 8.16
Center for Epidemiological Studies-Depression ScaleSecondary· at baseline, upon training completion (Week 4), and three months post baseline.
20-item Likert-type scale. Scores range from 0 to 60 with higher scores indicating greater depression.
Baseline
Group
Value
95% CI
Caregivers
14.83
± 9.30
Month 1
Group
Value
95% CI
Caregivers
14.78
± 9.45
Month 3
Group
Value
95% CI
Caregivers
12.98
± 9.40
State-Trait Anxiety InventorySecondary· at baseline, upon training completion (Week 4), and three months post baseline.
20-item Likert-type scale. Scores range from 20 to 80 with higher scores indicating greater anxiety.
Baseline
Group
Value
95% CI
Caregivers
36.15
± 10.27
Month 1
Group
Value
95% CI
Caregivers
35.38
± 11.09
Month 3
Group
Value
95% CI
Caregivers
34.85
± 11.62
Zarit Burden InventorySecondary· at baseline, upon training completion (Week 4), and three months post baseline.
22-item scale with 4-point Likert scale responses. Scores range from 0 to 88 with higher scores indicating greater burden.
Baseline
Group
Value
95% CI
Caregivers
61.95
± 16.32
Month 1
Group
Value
95% CI
Caregivers
61.63
± 15.19
Month 3
Group
Value
95% CI
Caregivers
59.68
± 16.43
Revised Memory and Behavioral Problems Checklist - FREQUENCYSecondary· at baseline, upon training completion (Week 4), and three months post baseline.
24-item scale with 4-point Likert scale responses. Scores range from 0 to 96 with higher scores indicating greater behavioral expressions observed by caregivers among persons living with dementia.
Baseline
Group
Value
95% CI
Caregivers
37.20
± 14.21
Month 1
Group
Value
95% CI
Caregivers
36.55
± 11.99
Month 3
Group
Value
95% CI
Caregivers
38.05
± 13.78
Quality of Life-Alzheimer's Disease ScaleSecondary· at baseline, upon training completion (Week 4), and three months post baseline.
13 items with a 4-point Likert scale. Scores range from 13 to with 52 with higher scores indicating greater quality of life among persons living with dementia
Baseline
Group
Value
95% CI
Caregivers
27.85
± 5.15
Month 1
Group
Value
95% CI
Caregivers
27.88
± 4.20
Month 3
Group
Value
95% CI
Caregivers
27.63
± 5.16
Revised Memory and Behavioral Problems Checklist - REACTIONSecondary· at baseline, upon training completion (Week 4), and three months post baseline.
24-item scale with 4-point Likert scale responses. Scores range from 0 to 96 with higher scores indicating greater behavioral expressions observed by caregivers among persons living with dementia.
Baseline
Group
Value
95% CI
Caregivers
20.13
± 13.27
Month 1
Group
Value
95% CI
Caregivers
19.70
± 12.21
Month 3
Group
Value
95% CI
Caregivers
16.35
± 12.05
Sponsor's own description
The goals of this clinical trial are to: 1) refine the training program, "Improving Care though Improv;" and 2) test the program for its influence self-perceived caregiving mastery (i.e., how persons assess their ability to provide care) among informal caregivers of persons living with moderate dementia. Forty-three informal caregivers will be involved in testing the training program. These individuals will be assigned to groups of between 8 to12 caregivers and take part in weekly 2-hour sessions held over a 4-week period. These caregivers will be taught improvisational (improv) theater skills, which involves being in the moment, self-awareness, and responsiveness to others. This group also will be asked to answer surveys questions about themselves and the person receiving care at three timepoints and invited to provide feedback on their training experiences.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
NCT06418971 — Testing & Refinement of CarePair: An Assessment and Referral Platform to Support Family Caregivers of Alzheimer's Diseas
· NA
· recruiting
NCT07153016 — LEgal Guidance and AdvocaCY for CAREgivers (LEGACY CARE): A Pilot Clinical Trial for Caregivers of Persons With Colorect
· NA
· recruiting
NCT07168577 — Sleep Quality and Caregiver Burden in Children With Cerebral Palsy
· recruiting
NCT07528261 — ACT Group for Stroke Caregivers
· NA
· recruiting
NCT06367556 — Emotion and Symptom-Focused Engagement (EASE) for Caregivers
· NA
· recruiting
Other Georgia State University trials
Trials by the same sponsor.
NCT07256275 — Peer Influences in Alcohol and Sexual Violence Among Marines Dyads
· recruiting
NCT06629428 — Effects of Ublituximab on Motor Functions in Multiple Sclerosis
· EARLY_PHASE1
· recruiting
NCT06787937 — Communicating About Nicotine Reduction in Cigarettes
· NA
· recruiting
NCT06730646 — Testing Different Anti-smoking Messages Among Chinese Young Adult Smokers and Nonsmokers
· NA
· completed
NCT06994624 — Clinical and Biochemical Effects of a Defined Plant-Based Diet on Heart Disease
· NA
· recruiting
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Georgia State University
Last refreshed: 11 June 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05996718.